Skip to content
PatentBrief
Get alertsTop ↑

How AI Designs New Protein Sequences for Specific Shapes

This patent describes a method where a computer-powered neural network fills in missing parts of a protein's amino acid sequence, ensuring the final protein has a desired 3D shape or "fold structure."

Granted 2026ActiveExpires 2040Owned by University of TorontoInvented by Alexey V. STROKACH, Philip M. KIM, David B. ROMERO + 2 more

Original patent title: “System and method for generating a protein sequence”

Plain-English explanation by SahiLast reviewed · November 2, 2026

This patent describes a method where a computer-powered neural network fills in missing parts of a protein's amino acid sequence, ensuring the final protein has a desired 3D shape or "fold structure.". Granted to University of Toronto in 2026 with 22 claims and 1 forward citation, and it is expected to expire in 2040.

Coverage

What does this patent actually cover?

The patent describes a computer-based method for designing protein sequences. It starts by taking an incomplete list of amino acids (called "node elements") for a protein and a map of how these amino acids should physically interact to form a specific 3D shape (an "edge index" defining a "desired fold structure"). A neural network then processes this information. It first figures out improved details about the interactions between amino acids ("enhanced edge attribute values") based on the known amino acids. Then, it uses these improved interaction details to determine better amino acid characteristics ("enhanced amino acid values") for each position. Finally, for any amino acid positions that were initially missing, the network generates the specific amino acid that should go there, completing the protein sequence to match the desired shape. For example, if you wanted a protein with a specific binding pocket, you could provide the known amino acids around that pocket and the desired distances between them, and the network would fill in the rest of the sequence.

The gap

What does this patent NOT cover?

  • Does not cover generating protein sequences without defining a desired physical interaction or "fold structure" beforehand.
  • Does not cover methods that predict a protein's 3D structure from an existing amino acid sequence.
  • Does not cover protein design approaches that do not use a computer-implemented neural network.
  • Does not cover generating protein sequences without an iterative refinement process of edge and node attributes.
  • Does not cover designing proteins where the "edge attribute value set" does not represent a characteristic of physical interaction, such as a Euclidean distance.

These exclusions are unique to PatentBrief — derived from the actual claim language, not patent-office boilerplate.

Key facts

Patent numberUS 12655176
StatusActive
FieldBiotech & Medicine
AssigneeUniversity of Toronto
InventorsAlexey V. STROKACH, Philip M. KIM, David B. ROMERO and 2 others
Filed2020
Granted2026
Expires2040
Claims22
Times cited1
LitigationNone on record
Value · $94K–$300KModest

What made this novel

The noveltynoveltyThe requirement that an invention be different from anything publicly known before its priority date.Read more → lies in the iterative refinement process where the neural network simultaneously enhances both the understanding of physical interactions (edge attributes) and the characteristics of individual amino acids (node attributes) based on a desired 3D structure. This allows it to fill in missing amino acids while ensuring the generated sequence is consistent with the target fold.

The Patent Drawing

Representative patent drawing for System and method for generating a protein sequence (US 12655176)
Representative figure · US 12655176All figures on Google Patents →
System and method for generati…(Primary claim)biotechsoftwareai mlpharmaceuticalmaterials

Schematic visualization of the patent's claim structure. Hand-drawn diagrams in progress for each landmark patent.

Where you've seen this

Real-world examples

01

Designing novel enzymes for industrial processes

02

Creating new therapeutic proteins with specific binding sites

03

Developing custom antibodies

04

Engineering proteins for biosensors

05

Designing stable protein scaffolds for drug delivery

Why it matters

The bigger picture

Proteins are the workhorses of biology, performing nearly all cellular functions. Being able to design new protein sequences that reliably fold into specific, desired 3D shapes is crucial for developing new drugs, enzymes, and biomaterials. This technology could accelerate the discovery of novel therapeutics or industrial catalysts by allowing researchers to computationally explore a vast space of potential protein designs.

Filed

December 4, 2020

Granted

June 16, 2026

Market context

Who's building on this

Companies in this space

Major pharmaceutical companies and biotech startups are heavily investing in AI-driven protein design. Companies like DeepMind (Alphabet), Generate Biomedicines, and Insilico Medicine are actively developing and applying machine learning models for de novo protein design and optimization. Academic institutions, including the University of Toronto (the assigneeassigneeThe entity that owns the patent — usually the inventor's employer or a company.Read more →), continue to be at the forefront of this research.

Market impact

This type of technology is transforming drug discovery and materials science. It enables the creation of novel proteins with tailored functions, potentially leading to new classes of therapeutics, vaccines, and industrial enzymes. By accelerating the design process, it significantly reduces the time and cost associated with traditional protein engineering, opening up new market opportunities for custom-designed biological molecules.

Claim 1 — Plain English

What this patent covers

The patent describes a computer-based method for designing protein sequences. It starts by taking an incomplete list of amino acids (called "node elements") for a protein and a map of how these amino acids should physically interact to form a specific 3D shape (an "edge index" defining a "desired fold structure"). A neural network then processes this information. It first figures out improved details about the interactions between amino acids ("enhanced edge attribute values") based on the known amino acids. Then, it uses these improved interaction details to determine better amino acid characteristics ("enhanced amino acid values") for each position. Finally, for any amino acid positions that were initially missing, the network generates the specific amino acid that should go there, completing the protein sequence to match the desired shape. For example, if you wanted a protein with a specific binding pocket, you could provide the known amino acids around that pocket and the desired distances between them, and the network would fill in the rest of the sequence.

The clever bit

The novelty lies in the iterative refinement process where the neural network simultaneously enhances both the understanding of physical interactions (edge attributes) and the characteristics of individual amino acids (node attributes) based on a desired 3D structure. This allows it to fill in missing amino acids while ensuring the generated sequence is consistent with the target fold.

What it does not cover

  • Does not cover generating protein sequences without defining a desired physical interaction or "fold structure" beforehand.
  • Does not cover methods that predict a protein's 3D structure from an existing amino acid sequence.
  • Does not cover protein design approaches that do not use a computer-implemented neural network.
  • Does not cover generating protein sequences without an iterative refinement process of edge and node attributes.
  • Does not cover designing proteins where the "edge attribute value set" does not represent a characteristic of physical interaction, such as a Euclidean distance.

Patent timeline

Filing

Application submitted to the patent office

Publication

Application published, typically 18 months after filing

Grant

Patent officially issued

Expiration

Patent enters public domain

PatentBrief Score

Impact Score

Strong

Citation count

6/40

Early citations

Claim breadth

15/20

Broad claimsclaimsThe numbered statements at the end of a patent that legally define what the inventor owns.Read more →

Recency

20/20

Granted within 5 years

Assignee scale

20/20

Major company or institution

PatentBrief Impact Score — based on citation count, claim breadth, recency, and assignee scale. Not a legal assessment.

Heuristic Value Estimate

What this patent might be worth

Modest

$94K – $300K

Midpoint $187K · 14.0 yr remaining · industry ×2.0

Adjust inputs →

Heuristic only — blends forward/backward citation counts, claim scope, time remaining, litigation history, and CPC-derived industry baseline. Real valuations need a professional appraisal.

Claim text not yet imported for this patent

The original legal language

Original claims

22 claims as filed with the patent office.

Concepts involved

ClaimPrior artNon-obviousnessNoveltySpecificationAssigneePatent term

Citations

Patent lineage

Cites earlier patents

11

earlier patents this invention cites as foundations

View prior art →

Cited by later patents

1

later patents that build on this invention

View patents →

Cite this patent

STROKACH, A. V., KIM, P. M., ROMERO, D. B., VERGE, C. C., & Riba, A. P. (2026). How AI Designs New Protein Sequences for Specific Shapes (U.S. Patent No. 12,655,176). U.S. Patent and Trademark Office. https://patentbrief.org/patent/us/12655176/system-and-method-for-generating-a-protein-sequence

Auto-generated from the patent record. Double-check author order and the issue date against the official USPTO document before submitting.

Embed

Add this patent to your site

Drop this plain-English patent card into any blog post or article — free, no signup. It always links back to the full breakdown here.

<div data-patentlens-widget data-patent-number="US12655176"></div>
<script src="https://patentbrief.org/embed.js" async></script>

Stay in the loop

Get a weekly digest of new patents.

One email per week. No spam. Unsubscribe anytime.

Keep exploring

Related patents you should know

US 4683195 · 1987

How to Make Billions of Copies of a DNA Segment

This patent describes the Polymerase Chain Reaction (PCR), a method to rapidly create many copies of a specific piece of DNA or RNA, enabling its detection and analysis.

Cetus Corp

US 8697359 · 2014

How to Edit Genes in Human Cells Using an Engineered CRISPR System

This patent describes an engineered CRISPR-Cas9 system for precisely cutting DNA in eukaryotic cells to change how genes work, opening the door for gene editing in complex organisms.

Massachusetts Institute of Technology

US 7657849 · 2010

How the iPhone's Slide-to-Unlock Gesture Works

Apple's 2010 patent describes unlocking a device by dragging a specific graphical image across the touchscreen along a predefined path, a gesture that became iconic with the original iPhone.

Apple Inc

US 4733665 · 1988

How Doctors Implant a Permanent Stent Using a Balloon

This patent describes the method for placing a permanent, expandable wire mesh tube inside a blood vessel or other body tube using a balloon-tipped catheter to widen it and keep it open.

Expandable Grafts Partnership

US 4965188 · 1990

How to Make Many Copies of a DNA Piece with Heat

This patent describes the Polymerase Chain Reaction (PCR) method, a technique to make millions of copies of a specific DNA segment using a heat-resistant enzyme and repeated temperature changes.

Cetus Corp

US 4235871 · 1980

How to Encapsulate Active Materials in Lipid Bubbles Efficiently

This patent describes a method for trapping biologically active substances inside tiny, multi-layered fat bubbles called liposomes, using a specific water-in-oil emulsion and gel-forming process to improve how much material gets captured.

Individual

Semantically similar

You might also find these interesting

SEARCH ALL

More to explore

More in Biotech & Medicine

Browse all Biotech & Medicine

New to patents?

What is a patent?How to read a patentAnatomy of a claimHow strong is this patent?What the citations meanWhat it doesn't coverBiotech PatentsPatent glossary
Explore the landscape:biotech patents →software patents →ai ml patents →

Common Questions

Frequently Asked Questions

What does How AI Designs New Protein Sequences for Specific Shapes cover?

This patent describes a method where a computer-powered neural network fills in missing parts of a protein's amino acid sequence, ensuring the final protein has a desired 3D shape or "fold structure."

Who owns patent US 12655176?

University of Toronto owns this patent, granted in 2026.

When does this patent expire?

This patent is expected to expire on December 4, 2040, when the invention enters the public domain.

What is patent US 12655176 cited by?

This patent has been cited by 1 later patents that build on its ideas.

What problem does this patent solve?

Proteins are the workhorses of biology, performing nearly all cellular functions. Being able to design new protein sequences that reliably fold into specific, desired 3D shapes is crucial for developing new drugs, enzymes, and biomaterials. This technology could accelerate the discovery of novel therapeutics or industrial catalysts by allowing researchers to computationally explore a vast space of potential protein designs.

What does this patent NOT cover?

Does not cover generating protein sequences without defining a desired physical interaction or "fold structure" beforehand.

Same assignee

More from University of Toronto

View all →
US 11501192·2022

How to Automatically Tune Machine Learning Settings Using Smart Math

Patent monitoring

Get notified when University of Toronto files a new patent

Get notified when this company files a new patent. Weekly digest · Confirm via email · Unsubscribe anytime.

Last reviewed: November 2, 2026 · PatentBrief is not a law firm and this is not legal advice.